Insights into aging obtained from p53 mutant mouse models

Annals of the New York Academy of Sciences

Volumn 1019, Issue , 2004, Pages 171-177

  Dumble, Melissa ^a   Gatza, Catherine ^a   Tyner, Stuart ^a   Venkatachalam, Sundaresan ^b   Donehower, Lawrence A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Accelerated aging; Aging model; Mouse; p53; Stem cells; Tumor suppressor

Indexed keywords

PROTEIN P53;

AGING; ALLELISM; CANCER RESISTANCE; CANCER SUSCEPTIBILITY; CELL PROLIFERATION; CONFERENCE PAPER; EXPERIMENTAL MODEL; GENE FUNCTION; GENE INACTIVATION; GENE MUTATION; KYPHOSIS; LONGEVITY; MOLECULAR DYNAMICS; MOLECULAR MECHANICS; NONHUMAN; OSTEOPOROSIS; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; STEM CELL; TISSUE REGENERATION; TUMOR SUPPRESSOR GENE; WOUND HEALING IMPAIRMENT;

MAMMALIA;

EID: 3242678797     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1297.027     Document Type: Conference Paper

References (12)

1. VAN ZANT, G. & Y. LIANG. 2003. The role of stem cells in aging. Exp. Hematol. 31: 659-672.
2. LEVINE, A.J. 1997. p53, the cellular gatekeeper for growth and division. Cell 88: 323-331.
3. VOGELSTEIN, B., D. LANE & A.J. LEVINE. 2000. Surfing the p53 network. Nature 408: 307-310.
4. DONEHOWER, L.A. 2002. Does p53 affect organismal aging? J. Cell. Physiol. 192: 23-33.
5. PALACIOS, R., C. BUCANA & X. XIE. 1996. Long-term culture of lymphohematopoietic stem cells. Proc. Natl. Acad. Sci. USA 93: 5247-5252.
6. SHOUNAN, Y., A. DOLNIKOV, K.L. MACKENZIE, et al. 1996. Retroviral transduction of hematopoietic progenitor cells with mutant p53 promotes survival and proliferation, modifies differentiation potential and inhibits apoptosis. Leukemia 10: 1619-1628.
7. DONEHOWER, L.A., M. HARVEY, B.L. SLAGLE, et al. 1992. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356: 215-221.
8. TYNER, S.D., S. VENKATACHALAM, J. CHOI, et al. 2002. p53 mutant mice that display early ageing-associated phenotypes. Nature 415: 45-53.
9. DONEHOWER, L.A. 1996. The p53-deficient mouse: a model for basic and applied cancer studies. Semin. Cancer Biol. 7: 269-278.
10. DIMRI, G.P., X. LEE, G. BASILE, et al. 1995. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 92: 9363-9367.
11. SELIVANOVA, G., V. IOTSOVA, I. OKAN, et al. 1997. Restoration of the growth suppression function of mutant p53 by a synthetic peptide derived from the p53 C-terminal domain. Nat. Med. 3: 632-638.
12. SELIVANOVA, G., L. RYABCHENKO, E. JANSSON, et al. 1999. Reactivation of mutant p53 through interaction of a C-terminal peptide with the core domain. Mol. Cell. Biol. 19: 3395-3402.